Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that using transcranial Doppler ultrasonography (a type of ultrasound) can help monitor changes in blood flow in the brain before and after surgeries like cranioplasty. This method is noninvasive and has been useful in assessing improvements in brain blood flow and predicting clinical outcomes after surgery.
12345Transcranial Doppler ultrasound (TCD) is a noninvasive procedure widely used in neurology and neurosurgery to monitor blood flow in the brain. It is considered safe and is commonly used in various settings, including during surgery and in emergency situations, without significant safety concerns reported.
678910Transcranial ultrasound for cranioplasty is unique because it uses sonolucent (ultrasound-transparent) cranial implants to allow ultrasound imaging of the brain after surgery, providing a non-invasive way to monitor brain health at the bedside. This approach differs from traditional methods that require direct access to the brain during surgery for imaging.
89111213Eligibility Criteria
This trial is for men and women aged 18 or older who are undergoing reconstructive sonolucent cranioplasty as standard care. Participants must be willing to follow study procedures and be available for the entire study duration. Pregnant individuals cannot participate.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Ultrasound imaging performed using FDA-approved devices to assess feasibility and efficacy compared to standard postoperative imaging
Follow-up
Participants are monitored for safety and effectiveness after treatment